Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-010771
Filing Date
2025-08-07
Accepted
2025-08-07 16:17:16
Documents
62
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgtx-20250630x10q.htm   iXBRL 10-Q 1367733
2 EX-31.1 cgtx-20250630xex31d1.htm EX-31.1 16606
3 EX-31.2 cgtx-20250630xex31d2.htm EX-31.2 16895
4 EX-32.1 cgtx-20250630xex32d1.htm EX-32.1 9970
5 EX-32.2 cgtx-20250630xex32d2.htm EX-32.2 10143
  Complete submission text file 0001558370-25-010771.txt   5629980

Data Files

Seq Description Document Type Size
6 EX-101.SCH cgtx-20250630.xsd EX-101.SCH 38017
7 EX-101.CAL cgtx-20250630_cal.xml EX-101.CAL 43548
8 EX-101.DEF cgtx-20250630_def.xml EX-101.DEF 137350
9 EX-101.LAB cgtx-20250630_lab.xml EX-101.LAB 357893
10 EX-101.PRE cgtx-20250630_pre.xml EX-101.PRE 268107
65 EXTRACTED XBRL INSTANCE DOCUMENT cgtx-20250630x10q_htm.xml XML 867707
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40886 | Film No.: 251194297
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)